Artiva Biotherapeutics, Inc. Shares Outstanding (Cover Page)
Artiva Biotherapeutics, Inc. (ARTV) had Shares Outstanding (Cover Page) of 48.89 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 48.89M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 24.72M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 24.72M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 24.54M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 48.89M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 24.72M shares 10-Q · filed 2026-05-08 |
| 2026-02-27 | 24.72M shares 10-K/A · filed 2026-04-30 |
| 2025-10-31 | 24.54M shares 10-Q · filed 2025-11-12 |
| 2025-07-31 | 24.43M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 24.36M shares 10-Q · filed 2025-05-08 |
| 2025-03-19 | 24.36M shares 10-K · filed 2025-03-24 |
| 2024-10-31 | 24.29M shares 10-Q · filed 2024-11-12 |
| 2024-08-15 | 24.29M shares 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |